机构：[1]State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, China.四川大学华西医院[2]West China School of Public Health and West China Fourth Hospital, Sichuan University, 610000, China.[3]Targeted Tracer Research and Development Laboratory, Precision Medicine Key Laboratory of Sichuan Province &[4]Precision Medicine Center, West China Hospital, Sichuan University, Chengdu, Sichuan, 610093, China.四川大学华西医院[4]School of Chemical Engineering, Northwest University, No.229 North Taibai Road, Xi'an, Shaanxi, 710069, China.[5]College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian 463000, China.[6]Laboratory of Anesthesia and Critical Care Medicine, National-Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology, West China Hospital, Sichuan University, China.四川大学华西医院[7]Sichuan Industrial Institute of Antibiotics, School of Pharmacy, Chengdu University, Chengdu, 610106, China.
This study was supported by Sichuan Science and Technology Program (NO：2019YFH0054). We thank Professor Tinghong Ye for
the guidance provided during the study.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类|3 区综合性期刊
小类|3 区综合性期刊
最新[2023]版：
大类|3 区综合性期刊
小类|3 区综合性期刊
第一作者：
第一作者机构：[1]State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Li Xiao,Wang Jia,Wang Qianqian,et al.A novel VEGFR inhibitor ZLF-095 with potent antitumor activity and low toxicity[J].Heliyon.2023,9(5):e15152.doi:10.1016/j.heliyon.2023.e15152.
APA：
Li Xiao,Wang Jia,Wang Qianqian,Luo Tianwen,Song Xuejiao...&Zhao Lifeng.(2023).A novel VEGFR inhibitor ZLF-095 with potent antitumor activity and low toxicity.Heliyon,9,(5)
MLA：
Li Xiao,et al."A novel VEGFR inhibitor ZLF-095 with potent antitumor activity and low toxicity".Heliyon 9..5(2023):e15152
